XGen Studios

Integrated DNA Technologies Reveals Launch of xGen™ Products for Ultima Genomics®

Retrieved on: 
Wednesday, September 27, 2023
Research, General Health, Pharmaceutical, Oncology, Technology, Infectious Diseases, Genetics, Health Technology, Science, Biotechnology, Other Technology, Health, Other Science, Learning, DNA, XGen Studios, Genomics, NGS, Integrated DNA Technologies, Ligation, Multimedia, RNA, Manager, Chemistry, IDT, Ultima, WGS, Small Business Saturday, Integration, PCR, Fine chemical, Antibiotics, Birth control, Paint

With a mission to accelerate the pace of genomics, Integrated DNA Technologies (IDT), a leading provider of differentiated next generation sequencing (NGS) solutions, announces the availability of xGen NGS products designed exclusively for the Ultima Genomics UG 100™ platform.

Key Points: 
  • With a mission to accelerate the pace of genomics, Integrated DNA Technologies (IDT), a leading provider of differentiated next generation sequencing (NGS) solutions, announces the availability of xGen NGS products designed exclusively for the Ultima Genomics UG 100™ platform.
  • The products are designed to minimize sequence errors from PCR or sequencing that might impact demultiplexing.
  • xGen HybCap Adapters for Ultima Genomics—full-length adapters for library construction prior to hybridization capture, using TA-ligation workflows for incorporating sample indexing during the ligation step.
  • xGen HybCap Lib Amp Primers for Ultima Genomics—premixed PCR primers used to increase yield for sequencing libraries post-hybridization capture.

Integrated DNA Technologies Launches New Respiratory Virus Panel

Retrieved on: 
Wednesday, July 19, 2023
Technology, Manufacturing, Health, General Health, Health Technology, Other Technology, Research, Other Manufacturing, Infectious Diseases, Genetics, Science, Influenza A virus subtype H1N1, XGen Studios, Respiratory tract infection, Therapy, SARS-CoV-2, Infection, NGS, Integrated DNA Technologies, COVID-19, Season, Multimedia, Doctor of Philosophy, IDT, RSV, R, Integration, Virus, A-DNA, Vaccine

To meet customer demand for a multiplexed, multiple respiratory disease target panel that provides comprehensive genome coverage, Integrated DNA Technologies (IDT) is revealing a new next generation sequencing (NGS) solution, the xGen Respiratory Virus Amplicon Panel .

Key Points: 
  • To meet customer demand for a multiplexed, multiple respiratory disease target panel that provides comprehensive genome coverage, Integrated DNA Technologies (IDT) is revealing a new next generation sequencing (NGS) solution, the xGen Respiratory Virus Amplicon Panel .
  • Leveraging IDT’s well-established NGS amplicon technology, the panel creates super amplicons to reliably distinguish identified and unidentified viral variants of multiple respiratory viruses in a single panel and allows for tracing evolving epidemiological patterns.
  • View the full release here: https://www.businesswire.com/news/home/20230719949441/en/
    Integrated DNA Technologies is revealing a new next generation sequencing (NGS) solution, the xGen™ Respiratory Virus Amplicon Panel, to support researchers as they combat the challenging diseases of today and prepare for the next pathogen of tomorrow.
  • The xGen Respiratory Virus Amplicon Panel is also compatible with IDT Normalase™ technology .

Integrated DNA Technologies Expands Access, Expedites Turnaround Time, for Minimal Residual Disease (MRD) Solutions for Cancer Research

Retrieved on: 
Wednesday, February 1, 2023
Other Health, Research, General Health, Oncology, Medical Devices, Infectious Diseases, Hospitals, Science, Biotechnology, Medical Supplies, Other Science, Health, DNA, Integration, Integrated DNA Technologies, IDT, Neoplasm, XGen Studios, PCR, MRD, Nucleic acid thermodynamics, Death, VAF, Multimedia, Cancer, Medical imaging, Pharmaceutical industry

To help researchers accurately measure circulating tumor DNA (ctDNA) from the most degraded and low-input samples, Integrated DNA Technologies today launched a complete MRD workflow for tumor-informed approaches.

Key Points: 
  • To help researchers accurately measure circulating tumor DNA (ctDNA) from the most degraded and low-input samples, Integrated DNA Technologies today launched a complete MRD workflow for tumor-informed approaches.
  • View the full release here: https://www.businesswire.com/news/home/20230201005337/en/
    Integrated DNA Technologies is helping researchers accurately measure circulating tumor DNA (ctDNA) from the most degraded and low-input samples with its newly launched complete MRD workflow for tumor-informed approaches.
  • (Photo: Business Wire)
    The launch expands access to IDT’s xGen MRD Hybridization Panel and xGen cfDNA & FFPE DNA Library Preparation Kit, which are now available as a bundled solution and aim to help scientists accelerate critical MRD research discoveries.
  • Alternatively, IDT’s PCR analysis options—such as the oPools™ Oligo Pools —can accommodate multiplexed PCR workflows for MRD research.

Ultima Genomics and Integrated DNA Technologies to Enable Application Portfolio on Ultima Sequencing Platforms

Retrieved on: 
Monday, February 6, 2023
IDT, Biomedical Research, XGen Studios, Genomics, NGS, Integration, Acquisition, Integrated DNA Technologies, Partnership, Fine chemical, Ultima

NEWARK, Calif., Feb. 6, 2023 /PRNewswire/ -- Ultima Genomics, Inc., a developer of a revolutionary new ultra-high throughput sequencing architecture, today announced a strategic collaboration with global genomics solutions provider Integrated DNA Technologies (IDT) to enable key next generation sequencing (NGS) applications on Ultima platforms.

Key Points: 
  • NEWARK, Calif., Feb. 6, 2023 /PRNewswire/ -- Ultima Genomics, Inc., a developer of a revolutionary new ultra-high throughput sequencing architecture, today announced a strategic collaboration with global genomics solutions provider Integrated DNA Technologies (IDT) to enable key next generation sequencing (NGS) applications on Ultima platforms.
  • Together, the companies plan to provide differentiated library preparation reagents and optimized workflows for users of Ultima's platform.
  • With a mission to accelerate the pace of genomics, IDT's comprehensive suite of xGen™ NGS library preparation kits and adapters offer flexible solutions to enable the sequencing of previously inaccessible sample types.
  • Scientists and researchers interested to learn more about Ultima Genomics sequencing platforms can find more information at https://www.ultimagenomics.com/publications-and-resources .

Next-generation Sequencing Library Preparation Global Market Report 2022: Industry to Reach $3.78 Billion at a CAGR 13.16% - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 28, 2022
Health, Genetics, Metagenomics, Cancer, QIAGEN, XGen Studios, Drug discovery, NGS, COVID-19, Biomarker, Application, USD, Disease, Hospital, Growth, Guinness, Genome, Severe acute respiratory syndrome coronavirus 2, IDT, WGS, Clifton Springs Hospital & Clinic, Microsatellite instability, Degenerative disease, University, Monkeypox, OncoDNA, Library, Chromosomal translocation, Incidence, Whole genome sequencing, Prevalence, Diagnosis, Antibiotics, Vaccine

The "Next-generation Sequencing Library Preparation Market Size, Share & Trends Analysis Report By Sequencing Type (Targeted Genome Sequencing, Whole Genome Sequencing), By Product, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Next-generation Sequencing Library Preparation Market Size, Share & Trends Analysis Report By Sequencing Type (Targeted Genome Sequencing, Whole Genome Sequencing), By Product, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global next-generation sequencing library preparation market size is expected to reach USD 3.78 billion by 2030.
  • Moreover, numerous market players offer a broad spectrum of solutions for NGS library preparation to suit the specific requirements of NGS-based analysis.
  • North America dominated the global NGS library preparation market in 2022, owing to the rising prevalence of diseases, increasing demand for early diagnosis, the need for genome sequencing, and the presence of key market players.

Integrated DNA Technologies Acquires ArcherDX Next Generation Sequencing Research Assays from Invitae Corporation

Retrieved on: 
Tuesday, December 20, 2022
Oncology, Health, Technology, Other Technology, Genetics, Research, Science, NGS, Archery, IDT, Triangle Park (Quezon City), NYSE, RNA, RUO, Mills, CRISPR, Synthetic biology, Genomics, Multimedia, RNA interference, Infection, XGen Studios, Biomarker, PCR, Integrated DNA Technologies, GMP, Research, Cancer, ISO, Acquisition, DNA sequencing, AMP, Fine chemical

Integrated DNA Technologies, Inc. (IDT) today announced it closed on the purchase of Next Generation Sequencing (NGS) research assays from Invitae Corporation (NYSE: NVTA) under the trademarked name Archer®.

Key Points: 
  • Integrated DNA Technologies, Inc. (IDT) today announced it closed on the purchase of Next Generation Sequencing (NGS) research assays from Invitae Corporation (NYSE: NVTA) under the trademarked name Archer®.
  • The NGS research assays were formally known as Invitae’s Research Use Only (RUO) kitted solutions.
  • Integrated DNA Technologies, Inc. (IDT) develops, manufactures, and markets nucleic acid products for the life sciences industry.
  • IDT has developed proprietary technologies for genomics applications such as next generation sequencing, CRISPR genome editing, synthetic biology, digital PCR, and RNA interference.

The Worldwide NGS Kits Industry is Expected to Reach $26 Billion by 2032: Exponential Rise in Next-Generation Sequencing (NGS) Demand due to Reducing Cost of Genome Sequencing - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 7, 2022
Technology, Biotechnology, Health, Other Health, Pharmaceutical, Other Science, Other Technology, Medical Devices, Infectious Diseases, General Health, Genetics, Science, COVID-19, Medical Supplies, Steps, IVD, Coronavirus, Virus, NGS, Integrated DNA Technologies, Marker beacon, Environment, Ion semiconductor sequencing, Diagnosis, Illumina, Inc., TSO, Biomarker, Thermo Fisher Scientific, ECS, Patient, Animal, Cancer, Beckman Coulter, Precision medicine, PCR, Integration, Region, XGen Studios, COVID-19, Growth, Multilocus sequence typing, PerkinElmer, Ion, RNA, Medical device, Medical imaging, Vaccine, Workflow, EU

The global NGS kits market is in progressing phase.

Key Points: 
  • The global NGS kits market is in progressing phase.
  • Next-generation sequencing (NGS) has recently seen a rapid surge in popularity and has emerged as a crucial diagnostic tool for many diseases.
  • NGS is a useful technology for characterizing and finding viruses in the environment, animals, and people during viral pandemics.
  • In June 2022, Beckman Coulter, Inc. partnered with Integrated DNA Technologies to distribute Biomek NGenius Next-Generation Sequencing Library Prep System.

Unlocking AI for End Devices: CoCoPIE Launches Industry-First DNN Model-Code Co-Optimization Tool (XGen) for Device AI

Retrieved on: 
Tuesday, July 12, 2022
Technology, Map, Privacy, IOT, Solution, PALO, DNN, CEO, CRSR, Android, XGen Studios, IOS, Computer, AI, Industry, CA, Medical device

PALO ALTO, Calif., July 12, 2022 /PRNewswire/ -- CoCoPIE today launched XGen, the first AI acceleration toolchain that co-optimizes the models and code of deep neural network (DNN), making AI models many times smaller and faster for use on devices while maintaining accuracy. The current release is mainly focused on smartphones. It is the first major milestone of CoCoPIE's efforts to clear the long-standing obstacles to AI deployment on end devices.

Key Points: 
  • It is the first major milestone of CoCoPIE's efforts to clear the long-standing obstacles to AI deployment on end devices.
  • Service providers and device makers want to run AI models on end devices to provide better experiences to their customers and save operations costs.
  • By removing the key roadblock to AI on end devices, CoCoPIE XGen allows businesses to capitalize on the huge market of device AI that had been beyond their reach.
  • "Through CoCoPIE XGen, businesses can significantly improve their AI capabilities on end devices," said Dr. Xiao-Feng Li, Co-founder and CEO of CoCoPIE.

Integrated DNA Technologies, Beckman Coulter Life Sciences Ink Distribution Deal

Retrieved on: 
Tuesday, June 7, 2022
Research, Technology, Genetics, Software, Biotechnology, Pharmaceutical, Health, Data Management, Science, Other Science, Goal, Google Chrome, RUO, CRISPR, IDT, GMP, Integration, Multimedia, PCR, Research, Triangle Park (Quezon City), Integrated DNA Technologies, Efficiency, Microsoft, Cancer, Beckman Coulter, Agriculture, Partnership, Solution, ISO, Diagnosis, Industry, Marketing, VP, XGen Studios, Electronics, RNA interference, RNA, Infection, Synthetic biology, Science, NGS, LinkedIn, Beckman, Disease, YouTube, Particle, Workflow, Twitter, Genomics, Instagram, Automation, Fine chemical, Medical device, Facebook

(Photo: Business Wire)

Key Points: 
  • (Photo: Business Wire)
    The distribution deal bolsters the partnership between IDT and Beckman Coulter Life Science and makes high-performance NGS solutions more accessible to fast-growing labs seeking to generate libraries more efficiently with out-of-the-box automation.
  • If your lifes calling is in any of these or related fields, you need to know Beckman Coulter Life Sciences.
  • Today, Beckman Coulter Life Sciences is a trusted, worldwide resource for tools to help optimize research and manufacturing efficiency.
  • Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein, including Biomek and Biomek NGeniuS System, are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

Integrated DNA Technologies Adds MLL Munich Leukemia Laboratory to Align Program

Retrieved on: 
Monday, March 21, 2022
Research, Technology, Genetics, Other Technology, Biotechnology, General Health, Health, Science, Oncology, Other Science, Marketing, Leukemia, LinkedIn, Informatics, Triangle Park (Quezon City), Synthetic biology, Lymphoma, Multimedia, NYSE, PCR, Research, NGS, Head, Program, Genomics, IDT, Cancer, RNA, Integration, MLL, Sequential structure alignment program, Agriculture, RNA interference, Industry, XGen Studios, Twitter, Sequence, Science, Solution, Immunophenotyping, YouTube, Danaher Corporation, GMP, CRISPR, Instagram, Patient, Integrated DNA Technologies, Infection, DHR, Fine chemical, Medical imaging, Facebook, IDT, MLL, IDT, MLL

On the heels of Integrated DNA Technologies xGen NGS portfolio launch in December, MLL, the Munich Leukemia Laboratory , one of the leading research and diagnostic laboratories for leukemias and lymphomas, has joined the global genomics solutions providers Align Program.

Key Points: 
  • On the heels of Integrated DNA Technologies xGen NGS portfolio launch in December, MLL, the Munich Leukemia Laboratory , one of the leading research and diagnostic laboratories for leukemias and lymphomas, has joined the global genomics solutions providers Align Program.
  • View the full release here: https://www.businesswire.com/news/home/20220321005107/en/
    On the heels of Integrated DNA Technologies xGen NGS portfolio launch, MLL, the Munich Leukemia Laboratory, one of the leading research and diagnostic laboratories for leukemias and lymphomas, has joined the global genomics solutions providers Align Program.
  • IDT builds meaningful partnerships with its Align Program members to open access to innovative NGS tools and technologies for the research community, and were proud to add MLL to our growing roster of preferred providers.
  • The MLL Munich Leukemia Laboratory is a nationally and internationally active laboratory working to diagnose cases of leukemia and lymphoma.